Vancomycin Utilization Evaluation at Hematology-Oncology Ward of a Teaching Hospital in Iran

被引:0
|
作者
Vazin, Afsaneh [2 ]
Japoni, Aziz [3 ]
Shahbazi, Sakineh [2 ]
Davarpanah, Mohammad Ali [1 ]
机构
[1] Shiraz Univ Med Sci, Shiraz HIV AIDS Res Ctr, Internal Med Ward, Shiraz, Iran
[2] Shiraz Univ Med Sci, Pharmaceut Res Ctr, Dept Clin Pharm, Fac Pharm, Shiraz, Iran
[3] Shiraz Univ Med Sci, Nemazee Hosp, Prof Alborzi Clin Microbiol Res Ctr, Shiraz, Iran
来源
关键词
Vancomycin; Drug utilization research; Appropriate drug use; Serum concentration; RESISTANT ENTEROCOCCUS-FAECIUM; RANDOMIZED CONTROLLED-TRIALS; INFECTIOUS-DISEASES SOCIETY; STAPHYLOCOCCUS-AUREUS; NEUTROPENIC PATIENTS; FEBRILE NEUTROPENIA; GLYCOPEPTIDE USE; OUTBREAK; THERAPY; METAANALYSIS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present study was to evaluate the pattern of vancomycin administration in the hematology-oncology ward of Nemazee Hospital, Shiraz, Iran. Study criteria were developed to assess the several parameters involved in vancomycin therapy. These parameters include the appropriateness of drug usage, dosage, duration of therapy, monitoring for toxicity and serum concentration monitoring. The serum concentration was measured by an automated Fluorescence Polarization Immunoassay. Clinical and preclinical parameters such as Glomerular Filtration Rate (GFR), microbial culture, antibacterial sensitivity, WBC count and fever were collected and recorded for analysis. Sixty patients were enrolled in the study, consisting of 45 males and 15 females. The age range was 15 to 68 years. In this study, 68.63% of the vancomycin used for the patients with febrile neutropenia was compatible with the Infectious Disease Society of America (IDSA) guideline. The initial dosage of vancomycin in 68.63%, rate of infusion in 100%, and dilution of vancomycin in 100%, were appropriate. Inappropriate use was more evident in the continuation of vancomycin in 50% of the patients. No appropriate dosage adjustment was done for 50% of the patients with increased serum creatinine. Based on the results, the indication of vancomycin in febrile neutropenia was satisfactory. However, there were some required factors such as continuation of vancomycin, adjustment of dosage or interval, microbial culture, antibiotic sensitivity test before the first dose administration, measurement of serum concentration and monitoring which had to be revised in order to achieve an effective treatment.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 50 条
  • [31] Vancomycin-Resistant Enterococcus in Hematology-Oncology Patients: a Review on Colonization, Screening, Infections, Resistance, and Antimicrobial Stewardship
    Miranda So
    Current Treatment Options in Infectious Diseases, 2020, 12 : 285 - 295
  • [32] Effects of Pharmacist Intervention on the Utilization of Vancomycin in a Teaching Hospital
    Tavakoli-Ardakani, Maria
    Ghassemi, Samaneh
    Alizadeh, Afshin Mohammad
    Salamzadeh, Jamshid
    Ghadiani, Mojtaba
    Ghassemi, Sara
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2015, 14 (04): : 1281 - 1288
  • [33] DRUG UTILIZATION REVIEW IN A TEACHING HOSPITAL - EXPERIENCE WITH VANCOMYCIN
    MISAN, GMH
    MARTIN, ED
    SMITH, ER
    SOMOGYI, AA
    BARTHOLOMEUSZ, RCA
    BOCHNER, F
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (05) : 457 - 461
  • [34] Evaluation for penetration and usage of Japanese guidelines on febrile neutropenia among hematology-oncology physicians
    Akiyama, Nobu
    Okamura, Takuho
    Kimura, Shun-ichi
    Yano, Shingo
    Yoshida, Isao
    Kusaba, Hitoshi
    Fujita, Hiroyuki
    Takahashi, Kosuke
    Fukushima, Keitaro
    Iwasaki, Hiromichi
    Yoshida, Minoru
    Saeki, Toshiaki
    Tamura, Kazuo
    Zenda, Sadamoto
    ANNALS OF ONCOLOGY, 2021, 32 : S321 - S321
  • [35] Healthcare-associated Infections in the Department of Pediatric Hematology-oncology; A Single Center Evaluation
    Ozdel, Zeynep Gizem Ergun
    Celebi, Solmaz
    Gunes, Adalet Meral
    Evim, Melike Sezgin
    Sevinir, Betul Berrin
    Baytan, Birol
    Demirkaya, Metin
    Kose, Serdal Kenan
    Cetin, Benhur
    Celik, Taylan
    Sali, Enes
    Hacimustafaoglu, Mustafa
    GUNCEL PEDIATRI-JOURNAL OF CURRENT PEDIATRICS, 2024, 22 (01): : 18 - 23
  • [36] Evaluation of the physician-patient communication assessment tool (CAT) in a hematology-oncology practice
    Desai, Amrita
    Olszewski, Adam J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31)
  • [37] EVALUATION OF EARLY EMPIRIC CEFTRIAXONE PROTOCOL FOR PEDIATRIC HEMATOLOGY-ONCOLOGY PATIENTS PRESENTING WITH FEVER
    Gallant, R.
    Bonney, P.
    Cruickshank, A.
    Crawford, D.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 592 - 593
  • [38] Albumin Utilization Evaluation in a Major Teaching Hospital in Iran: Recommendations for Guideline Development
    Farasatinasab, Maryam
    Amouzegar, Atefeh
    Safari, Saeed
    Ghanbari, Behrooz
    Darkahian, Majid
    Emami, Sepideh
    Pakdaman, Nashmin
    Salili, Maryam
    JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2018, 7 (03) : 157 - 163
  • [39] Evaluation of aminoglycosides utilization in intensive care units of a teaching hospital in southern Iran
    Vazin, Afsaneh
    Mirjalili, Mahtabalsadat
    Asadi, Sara
    PHARMACY PRACTICE-GRANADA, 2019, 17 (03):
  • [40] Iron deficiency anemia evaluation in a hematology-oncology population at a large academic medical center
    Harlan, Tracy
    Stein, Jill
    Fajardo, Susan
    McDanel, Deanna
    Sorenson, Susan
    PHARMACOTHERAPY, 2015, 35 (11): : E279 - E279